Oxford BioDynamics Plc (OBD) is a Biotechnology company in the Healthcare sector, listed on London Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for Oxford BioDynamics Plc in 2026. The next earnings report is expected on January 26, 2027.
Next earnings date
26 Jan 2027
In 159 days
EPS estimate
—
Revenue estimate
—
Past earnings
No dividend history available.
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic test for predicting response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling and biomarker discovery. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.
Oxford BioDynamics Plc (OBD) is scheduled to report earnings on January 26, 2027.
Oxford BioDynamics Plc (OBD) last reported earnings on June 30, 2026.
Oxford BioDynamics Plc (OBD) is listed on London Exchange.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.